[1]CurrentPatentAssignee:IPGROUPPLC-WO2014/207445,2014,A1Locationinpatent:Page/Pagecolumn46
[2]CurrentPatentAssignee:IPGROUPPLC-WO2016/97001,2016,A1Locationinpatent:Page/Pagecolumn44-45
[1]Wityak,John;McGee,KevinF.;Conlon,MichaelP.;Song,RenHua;Duffy,BryanC.;Clayton,Brent;Lynch,Michael;Wang,Gwen;Freeman,Emily;Haber,James;Kitchen,DouglasB.;Manning,DavidD.;Ismail,Jiffry;Khmelnitsky,Yuri;Michels,Peter;Webster,Jeff;Irigoyen,MacArena;Luche,Michele;Hultman,Monica;Bai,Mei;Kuok,IoktengD.;Newell,Ryan;Lamers,Marieke;Leonard,Philip;Yates,Dawn;Matthews,Kim;Ongeri,Lynette;Clifton,Steve;Mead,Tania;Deupree,Susan;Wheelan,Pat;Lyons,Kathy;Wilson,Claire;Kiselyov,Alex;Toledo-Sherman,Leticia;Beconi,Maria;Muñoz-Sanjuan,Ignacio;Bard,Jonathan;Dominguez,Celia[JournalofMedicinalChemistry,2015,vol.58,#7,p.2967-2987]
[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2015/116755,2015,A2
[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2015/116755,2015,A2
Title: trans-4-(2-Amino-5-bromo-6-methyl-pyrimidin-4-ylamino)-1-methyl-cyclo-hexa-nol.
Journal: Acta crystallographica. Section E, Structure reports online 20091001